Physician profile
Chawla Mason
NPI 1285831222
$2,322.24
in general payments reported to CMS, 2019-2025
8 companies · $1,036 in 2025
The $1,036 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $147 · 2024: $1,139 · 2025: $1,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $940 · Consulting Fee: $940 · Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $940.00 |
| Consulting Fee | $940.00 |
| Food and Beverage | $295.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,997.21 | 2024-2025 | Nellcor |
| Mindray Ds USA, INC. | $147.16 | 2022 | |
| Merck Sharp & Dohme LLC | $65.22 | 2025 | Bridion |
| Grifols Shared Services North America, INC. | $30.42 | 2025 | |
| Integra Lifesciences Corporation | $28.90 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Eagle Pharmaceuticals, INC. | $22.71 | 2024 | |
| Solventum Corporation | $16.37 | 2024 | Bair Hugger |
| Takeda Pharmaceuticals U.S.A., INC. | $14.25 | 2024 | Entyvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chawla Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.